Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

To study ASN008 for the treatment of chronic itch conditions and pain

Trial Profile

To study ASN008 for the treatment of chronic itch conditions and pain

Planning
Phase of Trial: Phase I

Latest Information Update: 08 May 2018

At a glance

  • Drugs ASN-008 (Primary)
  • Indications Pain; Pruritus
  • Focus Adverse reactions
  • Most Recent Events

    • 08 May 2018 According to the Asana BioSciences media release, yhe IND filing is planned in 2H 2018.
    • 05 Feb 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top